SCHEMBL30798908

SCHEMBL30798908

NC(=O)c1ccc(-n2ccnc2)c(F)c1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.42
MAPT P10636 3/20 0.42
CYP1A2 P05177 2/20 0.42
CYP2D6 P10635 2/20 0.42
MAPK1 P28482 2/20 0.42
CYP2C19 P33261 2/20 0.42
ALDH1A1 P00352 2/20 0.42
LMNA P02545 2/20 0.42
MEN1 O00255 1/20 0.42
CYP2C9 P11712 1/20 0.42
PMP22 Q01453 1/20 0.42
KMT2A Q03164 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
IDO1 P14902 3/20 0.41
BAZ2B Q9UIF8 1/20 0.39
CD38 P28907 1/20 0.38
NSD2 O96028 1/20 0.37
ADH5 P11766 1/20 0.37
BLM P54132 1/20 0.37
ENPP2 Q13822 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28812903 0.82 IDO1 (0.52) CYP3A4MAPTCYP1A2CYP2D6MAPK1
SCHEMBL30764860 0.81 CD38 (0.42) CYP3A4CYP1A2CYP2D6MAPK1CYP2C19
SCHEMBL7364258 0.76 IDO1 (0.57) CYP3A4MAPTCYP1A2CYP2D6MAPK1
Hydrochloric Acid SCHEMBL10438238 0.75 IDO1 (0.56) CYP3A4MAPTCYP1A2CYP2D6MAPK1
SCHEMBL15881145 0.75 SIRT3 (0.49) CYP3A4MAPTCYP1A2CYP2D6MAPK1
SCHEMBL31069770 0.75 ADH5 (0.49) CYP3A4MAPTLMNAIDO1BAZ2B
SCHEMBL30151934 0.75 ADH5 (0.49) CYP3A4MAPTCYP1A2CYP2D6CYP2C19
SCHEMBL811064 0.72 DGAT1 (0.52) CYP3A4MAPTMAPK1CYP2C19ALDH1A1
SCHEMBL29419925 0.72 IDO1 (0.47) CYP3A4MAPTCYP1A2CYP2D6MAPK1
SCHEMBL5319528 0.72 IDO1 (0.47) CYP3A4MAPTCYP1A2CYP2D6MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240116885-A1 BENZOTHIAZOLE AND QUINOLINE DERIVATIVES AND THEIR USE SHANGHAI YAO YUAN BIOTECHNOLOGY CO., LTD. (CN) 2024-04-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240116885-A1 BENZOTHIAZOLE AND QUINOLINE DERIVATIVES AND THEIR USE PHKA1, PHKA2, CSNK1A1 CYP3A4 1286/4885MAPT 691/4885CYP1A2 1067/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.